Hormonal evaluation in infertile men;Dosages hormonaux chez l'homme infertile

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 5, 2008, Pages 551-556

  Bourcigaux, N ^a   Christin Maitre S ^a  

^a Service d'endocrinologie de la reproduction   (France)

Author keywords

Endocrine male infertility; FSH; Inhibin; Testosterone

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE;

ARTICLE; CLINICAL ASSESSMENT; ENDOCRINE DISEASE; FOLLITROPIN BLOOD LEVEL; HORMONE ACTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MALE INFERTILITY; PROLACTIN BLOOD LEVEL; SEXUAL DYSFUNCTION; SPERMATOZOON DENSITY; TESTOSTERONE BLOOD LEVEL;

EID: 44049085496     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.03.006     Document Type: Article

References (30)

1. Male Infertility Best Practice Policy Committee of the American Urological Association; Practice Committee of the American Society for Reproductive Medicine. Report on evaluation of the azoospermic male. Fertil Steril 2006; 86(Suppl. 5):S210–5.
2. M. Sigman J.P. Jarow Endocrine evaluation of infertile men Urology 50 1997 659 664
3. Male Infertility Best Practice Policy Committee of the American Urological Association; Practice Committee of the American Society for Reproductive Medicine. Report on optimal evaluation of the infertile male. Fertil Steril 2006;86(Suppl. 5):S202–9.
4. C. Dode J. Levilliers J.-M. Dupont A. De Paepe N. Le Du N. Soussi-Yanicostas Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome Nat Genet 33 2003 463 465
5. C. Dode L. Teixeira J. Levilliers C. Fouveaut P. Bouchard M.-L. Kottler Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2 PLoS Genet 2 2006 e175
6. N. De Roux J. Young M. Misrahi R. Genet P. Chanson G. Schaison A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor N Eng J Med 337 1997 1597 1602
7. N. de Roux E. Genin J.-C. Carel F. Matsuda J.-L. Chaussain E. Milgrom Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 Proc Nat Acad Sci 100 2003 10972 10976
8. F. Muscatelli T.M. Strom A.P. Walker E. Zanaria D. Recan A. Meindl Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism Nature 372 1994 672 676
9. F. Lanfranco A. Kamischke M. Zitzmann E. Nieschlag Klinefelter's syndrome Lancet 364 2004 273 283
10. A. Ferlin B. Arredi E. Speltra C. Cazzadore R. Selice A. Garolla Molecular and clinical characterisations of Y chromosome microdeletions in infertile male J Clin Metab 92 3 2007 762 770
11. A. Ferlin C. Vinanzi A. Garolla R. Selice D. Zuccarello C. Cazzadore Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations Clin Endocrinol 65 2006 606 610
12. A. Qaseem M. Aronson N. Fitterman V. Snow K.B. Weiss D.K. Owens Clinical efficacy assessment subcommittee of the american college of physicians screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians Ann Intern Med 143 2005 517 521
13. M. Abalovich O. Levalle R. Hermes H. Scaglia C. Aranda C. Zylbersztein Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males Thyroid 9 1999 857 863
14. P. Enzlin A. Coviello R. Basson Sexual dysfunction in men and women with endocrine disorders Lancet 369 2007 597 611
15. A. Vermeulen L. Verdonck J.M. Kaufmann A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 10 1999 3666 3672
16. W. Rosner R.J. Auchus R. Azziz P.M. Sluss H. Raff Utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement J Clin Endocrinol Metab 92 2007 405 413
17. K. Sikaris R.I. McLachlan R. Kazlauskas D. de Kretser C.A. Holden D.J. Handelsman Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays J Clin Endocrinol Metab 90 2005 5928 5936
18. J.S. Tapanainen K. Aittomaki J. Min T. Vaskivuo I.T. Huhtaniemi Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility Nat Genet 15 1997 205 206
19. G. Schaison J. Young M. Pholsena K. Nahoul B. Couzinet Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism J Clin Endocrinol Metab 77 1993 1545 1549
20. J.D. Meeker L. Godfrey-Bailey R. Hauser Relationships between serum hormone levels and semen quality among men from an infertility clinic J Androl 28 2007 397 406
21. T.R. Kumar Functional analysis of LHbeta knockout mice Mol Cell Endocrinol 15 2007 269
22. J. Weiss L. Axelrod R.W. Whitcomb P.E. Harris W.F. Crowley J.L. Jameson Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone N Eng J Med 326 1992 179 183
23. H. des-Socin R. Salvi A.F. Daly R.C. Gaillard P. Quatresooz P.-M. Tebeu Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene N Eng J Med 351 2004 2619 2625
24. F.H. Pierik J.T. Vreeburg T. Stijnen F.H. De Jong R.F. Weber Serum inhibin B as a marker of spermatogenesis J Clin Endocrinol Metab 83 1998 3110 3114
25. M. Appasamy S. Muttukrishna A.R. Pizzey O. Ozturk N.P. Groome P. Serhal Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility Reprod Biomed Online 14 2007 159 165
26. V. Vernaeve F. Brugnon H. Tournaye Inhibin B, predictive factor for testicular sperm recovery? Gynecol Obstet Fertil 32 2004 767 770
27. V. Vernaeve H. Tournaye J. Schiettecatte G. Verheyen A. Van Steirteghem P. Devroey Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia Hum Reprod 17 2002 971 976
28. S. Von Eckardstein M. Simoni M. Bergmann G.F. Weinbauer P. Gassner A.G. Schepers Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples J Clin Endocrinol Metab 84 1999 2496 2501
29. M. Fujisawa T. Yamasaki H. Okada S. Kamidono The significance of anti-Müllerian hormone concentration in seminal plasma for spermatogenesis Hum Reprod 17 2002 968 970
30. M. Fujisawa T. Yamasaki I. Okada S. Kamidono The significance of anti-mullerian hormone concentration in seminal plasma for spermatogenesis Hum Reprod 17 4 2002 968 970